Back to Search
Start Over
Inflammatory cytokines and vascular endothelial growth factor stimulate the release of soluble tie receptor from human endothelial cells via metalloprotease activation.
- Source :
-
Blood [Blood] 1999 Mar 15; Vol. 93 (6), pp. 1969-79. - Publication Year :
- 1999
-
Abstract
- Activation of endothelial cells, important in processes such as angiogenesis, is regulated by cell surface receptors, including those in the tyrosine kinase (RTK) family. Receptor activity, in turn, can be modulated by phosphorylation, turnover, or proteolytic release of a soluble extracellular domain. Previously, we demonstrated that release of soluble tie-1 receptor from endothelial cells by phorbol myristate acetate (PMA) is mediated through protein kinase C and a Ca2+-dependent protease. In this study, the release of soluble tie-1 was shown to be stimulated by inflammatory cytokines and vascular endothelial growth factor (VEGF), but not by growth factors such as basic fibroblast growth factor (bFGF) or transforming growth factor alpha (TGFalpha). Release of soluble tie by tumor necrosis factor alpha (TNFalpha) or VEGF occurred within 10 minutes of stimulation and reached maximal levels within 60 minutes. Specificity was shown by fluorescence-activated cell sorting (FACS) analysis; endothelial cells exhibited a significant decrease in cell surface tie-1 expression in response to TNF, whereas expression of epidermal growth factor receptor (EGF-R) and CD31 was stable. In contrast, tie-1 expression on megakaryoblastic UT-7 cells was unaffected by PMA or TNFalpha. Sequence analysis of the cleaved receptor indicated that tie-1 was proteolyzed at the E749/S750 peptide bond in the proximal transmembrane domain. Moreover, the hydroxamic acid derivative BB-24 demonstrated dose-dependent inhibition of cytokine-, PMA-, and VEGF-stimulated shedding, suggesting that the tie-1 protease was a metalloprotease. Protease activity in a tie-1 peptide cleavage assay was (1) associated with endothelial cell membranes, (2) specifically activated in TNFalpha-treated cells, and (3) inhibited by BB-24. Additionally, proliferation of endothelial cells in response to VEGF, but not bFGF, was inhibited by BB-24, suggesting that the release of soluble tie-1 receptor plays a role in VEGF-mediated proliferation. This study demonstrated that the release of soluble tie-1 from endothelial cells is stimulated by inflammatory cytokines and VEGF through the activation of an endothelial membrane-associated metalloprotease.
- Subjects :
- Amino Acid Sequence
Animals
CHO Cells
Cells, Cultured
Cricetinae
Enzyme Activation
Fibroblast Growth Factor 2 pharmacology
Humans
Interleukin-1 pharmacology
Kinetics
Molecular Sequence Data
Peptide Fragments chemistry
Receptor Protein-Tyrosine Kinases chemistry
Receptor, TIE-1
Receptors, TIE
Tetradecanoylphorbol Acetate pharmacology
Transforming Growth Factor alpha pharmacology
Tumor Necrosis Factor-alpha pharmacology
Umbilical Veins
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factors
Cytokines pharmacology
Endothelial Growth Factors pharmacology
Endothelium, Vascular enzymology
Lymphokines pharmacology
Metalloendopeptidases metabolism
Receptor Protein-Tyrosine Kinases metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 0006-4971
- Volume :
- 93
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Blood
- Publication Type :
- Academic Journal
- Accession number :
- 10068670